In the Media

Profs. Robert Langer, Giovanni Traverso and former postdoctoral fellow Thomas von Erlach have founded Vivtex, a biotechnology startup specializing in “oral alternatives to drugs administered by injections,” reports Jonathan Satlzman for The Boston Globe. Vivtex, now working in collaboration with Novo Nordisk, is looking to develop a new class of “pills to treat obesity and diabetes,” explains Saltzman.